Reform of evaluation and approval system of traditional Chinese medicine and the registration classificationWANG Hai-nan193-196
Introduction and comparison of guidelines for bioequivalence evaluation of inhalantsZHOU Qin-lei, GUAN Yan-ping, LIU Xiao-lin, HUANG Min, ZHONG Guo-ping197-204
Management of bioequivalence trials for endogenous agentsLIU Jing, XU Ming, LIU Hong-jiao, ZHOU Fa-jun, LIU Chuan205-208
A preliminary analysis of remote monitoring practice in clinical trialsFU Zhi-ying, LIU Xiao-hong, ZHAO Shu-hua, YUAN Yan-nan, JIANG Min209-214
Research progress of Toll-like receptors in chronic diseasesZHANG Ming-lu, WU Yan-lin, ZHANG Yuan, GAO Hua215-219
Investigation and research on the current situation of experimental drug management in 16 pediatric clinical trial institution in ChinaWU Wen-wen, DING Qian, XU Jing, WANG Xiao-ling220-225
Study on the correlation between the particle size distribution of meclofenoxate hydrochloride for injection and the weight variationWANG Lin, WU Bin, SUN Yi, AN Jing-ye, WU Zhao-wei, WU Ke-chun, ZHANG Zhe, HU Qin, YANG Wen-liang, WANG Tie-song226-231
Research progress on design of multi-target anticancer drugs based on histone deacetylasesDING Jiao-li, ZHANG Zhi-peng, LIU Jing, ZHOU Wei-xin, JIN Yi, XIE Sai-sai236-245
Research progress of oncolytic virus combined with other drugs in cancer therapyCUI Jiao-yan, CAI Shi-jie246-253